In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.
Mol Cancer Ther
; 11(1): 194-203, 2012 Jan.
Article
em En
| MEDLINE
| ID: mdl-22090421
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinona Redutases
/
NF-kappa B
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article